肺癌放疗标准PPT.ppt

Update in Radiotherapy for Non-Small Cell Lung Cancer;Radiotherapy for NSCLC;Definitive Radiotherapy for Early Stage NSCLC;the therapy provided a 98% rate of local control! ;Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non–Small-Cell Lung Cancer;Authors;Authors;Mountain *;(A);SBRT has been becoming standard treatment for inoperable stage I NSCLC How about operable stage I NSCLC?;Randomized Studies are on the Way! ;Definitive Radiotherapy for Early Stage NSCLC;Can the clinical early stage Pts be given a thorough Staging?;Definitive Concurrent Chemo-Radiotherapy for Locally Andvanced NSCLC;Definitive Concurrent Chemo-Radiotherapy for Locally Advanced NSCLC;;Form H Choy;Form H Choy;But How Many Patients with Locally Advanced NSCLC Can Accept Concurrent Chemo-radiotherapy?;278 of 686 (41%) of the whole patient group was eligible for concurrent chemoradiation. ;Ruysscher, D. D. et al. Ann Oncol 2009 20:98-102; ;Data from Cancer Hospital of CAMSComparison of comorbidity per age (1);Data from Cancer Hospital of CAMS Comparison of comorbidity per age (2);Percentage of Pts eligible for concurrent chemoradiotherapy;Treatment Features;Interaction of age and systemic treatment (chemotherapy) ;important implications;New radiation techniques improved treatment results;Image-Guided Radiation Delivery IGRT;Better location for patient position;Better location for tumor;Accurate irradiation to target volume;Control tumor moving in breath;4-Direction CT imaging technique;Use of advanced radiation technologies have translated into improvement of survival;Int. J. Radiation Oncology Biol. Phys., Vol. 66, No. 1, pp. 108–116, 2006;Int. J. Radiation Oncology Biol. Phys., Vol. 66, No. 1, pp. 108–116, 2006;Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy ; Conclusions1、Treatment with 4DCT/IMRT was at least as good